BBW
Build-A-Bear Workshop, Inc.
BBW has the edge over LCID overall, supported by lower modeled downside and stronger valuation.
LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BBW Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
BBW's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BBW PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.4x | $25.92 | -8.8% |
| Current | 7.1x | $28.41 | — |
| Forward | 7.7x | $28.41 | — |
| Fair | 8.2x | $33.17 | +17% |
| Expensive | 12x | $49.33 | +74% |
Historical ranges are pointers, not guarantees.
BBW's PE is in its cheap range at 7.0x. On analysts' estimates for next year's earnings, today's price would be 7.7x, in its fair range.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
BBW Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect BBW's earnings to grow and its profitability to improve, with its revenue holding steady.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BBW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.70 | -8.3% |
| Q3 2026 | $4.03 | -9.4% |
| Q2 2026 | $4.27 | +2.9% |
| Q1 2026 | $3.99 | +5% |
| Q4 2025 | $4.34 | +15% |
| Q3 2025 | $4.45 | +25% |
| Q2 2025 | $4.15 | +19% |
| Q1 2025 | $3.80 | +4.1% |
| Q4 2024 | $3.76 | +9% |
BBW has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
BBW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $115.3M | -7.2% |
| Q2 2026 | $125.3M | -2.4% |
| Q1 2026 | $154.5M | +2.7% |
| Q4 2025 | $122.7M | +2.7% |
| Q3 2025 | $124.2M | +11% |
| Q2 2025 | $128.4M | +12% |
| Q1 2025 | $150.4M | +0.8% |
| Q4 2024 | $119.4M | +11% |
BBW's revenue grew through 2023 and has held roughly level since: $115M last quarter, down 7.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | -2.2 points |
| Q2 2026 | 19% | +3.8 points |
| Q1 2026 | 14% | -4.3 points |
| Q4 2025 | 8.8% | -2.2 points |
| Q3 2025 | 12% | +2 points |
| Q2 2025 | 15% | +2.2 points |
| Q1 2025 | 18% | +0.8 points |
| Q4 2024 | 11% | +1.3 points |
BBW has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over BBW on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
BBW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.6M | -528% |
| Q2 2026 | $14.4M | -42% |
| Q1 2026 | $12.1M | +24% |
| Q4 2025 | $1.7M | -85% |
| Q3 2025 | $849K | +$2.1M |
| Q2 2025 | $24.9M | +214% |
| Q1 2025 | $9.8M | -60% |
| Q4 2024 | $11.3M | +$15.4M |
BBW has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
BBW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.6% | -207K shares |
| 1 year | -5.4% | -708K shares |
| 3 years | -14% | -2.1M shares |
| 5 years | -23% | -3.7M shares |
| Available history | -16% | -2.3M shares |
BBW has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5.6M |
| Q2 2026 | $11.5M |
| Q1 2026 | $10.2M |
| Q4 2025 | $10.2M |
| Q3 2025 | $3.1M |
| Q2 2025 | $4.2M |
| Q1 2025 | $8.1M |
| Q4 2024 | $4.8M |
BBW spent $38M buying back its own shares over the past year, up 86% from the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
BBW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
BBW has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BBW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.9 | Neutral |
| Stochastic | 31.7 | Neutral |
BBW's weekly RSI is 43 (neutral) and its Stochastic is 32 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BBW PE vs Consumer Cyclical Sector
| Metric | BBW | Sector median | Relative |
|---|---|---|---|
| PE | 7.1x | 18x | 61% below |
| PE % | 26 | 47 | 21 pts below |
BBW is trading at 7.0x earnings, a 61% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
BBW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.4 | 7.5% above |
| 20 week MA | $30.2 | 6% below |
| 50 week MA | $39.6 | 28% below |
| 100 week MA | $44.0 | 35% below |
| 200 week MA | $35.3 | 19% below |
BBW has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
BBW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.22 | $3.96 | +23% |
| 2021 | $3.96 | $17.3 | +337% |
| 2022 | $17.3 | $23.2 | +34% |
| 2023 | $23.2 | $23.0 | -1% |
| 2024 | $23.0 | $46.7 | +103% |
| 2025 | $46.7 | $62.3 | +34% |
| 2026 YTD | $62.3 | $28.4 | -54% |
BBW has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.